It was proposed previously that the FHA2 domain of the yeast protein kinase Rad53 has dual speci®city toward pY and pT peptides. The consensus sequences of pY peptides for binding to FHA2, as well as the solution structures of free FHA2 and FHA2 complex with a pY peptide derived from Rad9, have been obtained previously. We now report the use of a pT library to screen for binding of pT peptides with the FHA2 domain. The results show that FHA2 binds favorably to pT peptides with Ile at the 3 position. We then searched the Rad9 sequences with a pTXXI/L motif, and tested the binding af®nity of FHA2 toward ten pT peptides derived from Rad9. One of the peptides, 599 EVEL(pT)QELP 607 , displayed the best binding af®nity (K d 12.9 mM) and the greatest chemical shift changes. The structure of the FHA2 complex with this peptide was then determined by solution NMR and the structure of the complex between FHA2 and the pY peptide 826 EDI(pY)YLD 832 was further re®ned. Structural comparison of these two complexes indicates that the Leu residue at the 3 position in the pT peptide and that at the 2 position in the pY peptide occupy a very similar position relative to the binding site residues from FHA2. This can explain why FHA2 is able to bind both pT and pY peptides. This position change from 3 to 2 could be the consequence of the size difference between Thr and Tyr. Further insight into the structural basis of ligand speci®city of FHA domains was obtained by comparing the structures of the FHA2-pTXXL complex obtained in this work and the FHA1-pTXXD complex reported in the accompanying paper.
Introduction
A novel phosphoprotein binding domain, known as forkhead-associated (FHA) domain, facilitates protein-protein interactions in many pathways of cell-cycle control, such as transcription factors, protein kinases, protein phosphatases, and kinase-associated proteins, from prokaryotes to eukaryotes. It was previously reported to consist of 55-75 residues with three considerably conserved regions separated by two divergent spacer sequences. 1 However, it has been shown that the structurally intact FHA domains contain approximately 160 residues. 2, 3 The two FHA domains of the protein kinase Rad53 in Saccharomyces cerivisiae, designated as FHA1 domain (N-terminal) and FHA2 domain (Cterminal), have been characterized extensively. Previous studies have demonstrated that, in response to DNA damage at the G2/M phase, FHA2 domain interacts with phosphorylated Rad9 (Rad9p). 4 We have reported the solution structures of both FHA1 and FHA2 domains recently. 2, 5 Both structures show a remarkably similar folding, which comprises 11 b-stands linked by several loops to form two large twisted antiparallel bsheets folded into a b-sandwich. We have also used combinatorial library approaches to identify the ligand speci®city of both domains, and solved the solution structures of the complexes. 6, 7 It appears that the FHA1 domain is highly speci®c to pT peptides. 5, 8 On the basis of relative binding af®-nities of different pT peptides derived from Rad9, we have suggested that Thr192 of Rad9 is most likely to be the residue that is phosphorylated and recognized by the FHA1 domain of Rad53. 5 The structural nature of the ligand speci®city of FHA1 has been addressed in detail. 7, 8 Here, we focus on the ligand speci®city of the FHA2 domain of Rad53. In contrast to FHA1, our previous studies have shown that FHA2 interacts with pY peptides and preliminarily with pT peptides. 2, 6 Furthermore, the solution structure of the FHA2 complex with a Rad9-derived pY peptide, 826 EDI(pY)YLD 832 , illustrated that the interaction was mediated via hydrophobic interaction involving Leu at the 2 position relative to pY. 6 We have hypothesized that the FHA domain could have pT and pY dual speci®city, or that different FHA domains could have different speci®city. To substantiate this hypothesis, we now report the results of screening pT peptide libraries for binding to FHA2, as well as the solution structure of the complex of FHA2 with a speci®c pT peptide. Detailed analyses of the FHA2-pT peptide complex and the FHA2-pY peptide complex have shed light on the structural nature of the ligand speci®city of FHA2, and on the differences between the ligand speci®cities of FHA2 and FHA1 domains.
Results and Discussion
Screening of a pT peptide library for binding to FHA2
Our strategy for screening a pT peptide library for binding to FHA2 is the same as that described previously for binding to FHA1, using the same pT peptide library acetyl-AXXX(pT)XXXABBRMresin. 5 The feasibility of using this library to identify consensus sequences is addressed in the accompanying paper. 7 Screening of 120 mg of resin (ca 360,000 individual beads) led to identi®cation of $500 positive beads. Among them, 288 beads were subjected to sequence analysis by MALDI-TOF mass spectrometry. High-quality mass spectra were obtained for 184 samples. The frequencies of amino acids at each position, À3, À2, À1, 1, 2, and 3 relative to pT residue are shown in Figure 1 .
Detailed analyses of the results in Figure 1 suggest the following important results. (a) Arginine and, to a less extent, lysine are highly preferred at each position. The unusually high abundance of these positively charged residues at most positions raised the possibility that it is caused by non-speci®c interactions. To test this possibility, a peptide containing Arg at all pos- Figure 1 . The results of combinatorial pT peptide library screening for binding to FHA2 domain, demonstrating the preference of amino acids at positions À3 to 3 relative to the pT residue of pT peptide sequences. The x-axis represents the identity of the 19 amino acids in single-letter codes, while the y-axis indicates the frequency of observing the amino acid at a particular position. M represents norleucine.
itions, ARRR(pT)RRR, was designed and tested for binding ability to FHA2. The 15 N-HSQC experiments revealed that this peptide induces no chemical shift change on FHA2 (data not shown). (b) In contrast to the previous studies of FHA1, which showed a nearly absolute requirement of Asp at the 3 position of pT peptides, 5, 8 the result of FHA2 indicates very low abundance of Asp at the 3 position. The structural basis of this difference is addressed in later sections. (c) Instead of the highly polar Asp residue, the highly hydrophobic residue Ile is the most preferred at the 3 position (after ignoring the non-speci®c Arg). Using a different screening approach, Durocher et al. also concluded that (pT)XXI/L is the most preferred binding motif for the FHA2 domain. 8 A pT peptide containing Ile at position 3, ASNQ(pT)FVI, which was arbitrarily chosen from the sequences of positive beads, was tested and shown to induce substantial chemical shift changes in 15 N-HSQC spectra of FHA2 (data not shown). The K d value was ca 72 mM, as determined by surface plasmon resonance analysis. (d) Qualitatively, the results of peptide screening suggest that the FHA2 domain has relatively weak af®nity for pT peptides, such that non-speci®c interactions with arginine residues become detectable. (e) The library screening experiment of the pT peptide/FHA2 reaction displayed less color intensity compared to that of the pT peptide/FHA1 reaction. 5 This qualitative comparison could suggest that the af®nity of FHA2 for pT peptides is weaker than that of FHA1.
Identification of possible pT sites of Rad9 involved in FHA2 binding
Our approach has been to use the results from library screening to identify possible Rad9 residues involved in the interaction with Rad53. In the case of the FHA1 domain, we have identi®ed a tightbinding peptide from Rad9, and we suggest that it likely represents the biological binding site for FHA1. 5 In this section, we describe the results of our effort in identifying a possible pT binding site on Rad9 for binding of FHA2.
Since the previous study demonstrated that the interaction between Rad9 and FHA2 is localized in the fragment consisting of Rad9 residues 553-1056, 4 we focused on the TXXI/L motif (Leu is included due to its similarity to Ile) within this Rad9 fragment. Figure 2 ) and highest binding af®nity (K d 12.9 mM). This peptide was then used to determine the solution structure of the FHA2-pT peptide complex (see later). The tenth peptide consisting of ®ve positive charges did not induce chemical shift changes.
The above results suggest that the residues 599 EVEL(pT)QELP 607 of Rad9 represent a potential binding site for FHA2. However, the evidence is not suf®cient to suggest that it is the actual binding site. As shown in Table 1 from Rad9 with an estimated K d of 100 mM. 2 The results taken together lend further support to our suggestion that FHA2 has dual speci®city toward phosphopeptides. However, its actual biological binding site on Rad9 remains to be established.
The results raise important structural questions: how does FHA2 bind to both pY and pT peptides with different sequences, but with comparable af®- 
FHA2 binds pS peptides weakly
The FHA2 domain was examined for binding to the pS library, acetyl-AXXX(pS)XXXABBRM-resin. Under the same conditions of library screening, signi®cantly more blue beads were obtained for FHA2 in comparison with FHA1. However, no clear consensus sequence could be identi®ed from the mass spectrometry analysis (data not shown). Qualitatively, our results suggest that the FHA2 domain could probably bind pS peptides better than the FHA1 domain does, but the binding af®-nity is weak relative to pT and pY peptides. Like FHA1, 7 little chemical shift change was observed when the pT peptide used for the complex structure determination was replaced by the corresponding pS peptide, EVEL(pS)QELP.
Solution structure of the FHA2-pT peptide complex
This section describes the use of NMR to determine the structure of the FHA2 complex with the pT peptide 599 EVEL(pT)QELP 607 . Intermolecular NOE distance restraints for structure calculation were obtained mostly from the 3D The NOEs came mainly from the pT residue and the three residues at the C-terminal side of pT, i.e. residues 1 to 3. A total of 53 intermolecular NOEs were deduced from such NOE analyses. Structural calculation of the complex was performed using these purely NOE-derived intermolecular distance restraints, along with 3109 intramolecular distance restraints within FHA2, 19 intramolecular distance restraints within the pT peptide, and 188 torsional angle restraints derived from Program TALOS. 9 The 20 superimposed complex structures are shown in Figure 4 (a), and a summary of structural statistics is provided in Table 2 . The complex structures satisfy the exper- imental restraints very well, and show good covalent geometry, non-bonded energy, and Ramachandran plot ( Table 2 ). The structures of the FHA2 domain in the complex are very well converged, with RMSD values of 0.36(AE0.07) A Ê and 0.78(AE0.05) A Ê for the backbone and all heavy atoms, respectively. The peptide structures are reasonably well converged for the residues from pT to the 3 residue: the RMSD values are 0.79(AE0.17) A Ê and 1.14(AE0.16) A Ê for the backbone and all heavy atoms, respectively (Table 2 and Figure 4(a) ).
The structures show that the guanidino groups of Arg605 and Arg620, but not Arg617, are in close contact with the phosphate group of the peptide: an average distance of 6.3(AE0.5) A Ê was observed between the P atom of the pT peptide and the Arg605 C z atom, and 5.8(AE0.8) A Ê for the corresponding distance with Arg620, whereas 12.5(AE0.6) A Ê was observed for Arg617.
Refined solution structure of the FHA2-pY peptide complex
Recently, we have reported a complex structure of FHA2-pY peptide where the pY peptide was derived from Rad9, 826 EDI(pY)YLD 832 . 6 In the structural calculation, we used 18 intermolecular distance restraints obtained from NOE data, as well as three arti®cial distance restraints between the P atom of pY and the C z atoms of Arg605, Arg617, and Arg620 of FHA2. The arti®cial restraints were introduced on the basis of the 15 N HSQC titration data, as well as the result of preliminary structural analysis without using arti®cial restraints.
We have now re®ned this complex structure by assigning eight additional intermolecular NOEs (to a total of 26), which allowed us to calculate the complex structure without using any arti®cial distance restraint. Also used in the calculation were 3108 intramolecular NOEs from the FHA2 domain, 76 intramolecular distance restraints from the pY peptide, and 188 torsion angle restraints derived from Program TALOS. 9 The 22 superimposed complex structures are shown in Figure 4 (b), and the structural statistics are summarized in Table 3 . The structures of the FHA2 domain in the complex are very well converged, with RMSD values of 0.35(AE0.04) A Ê and 0.80(AE0.06) A Ê for the backbone and all heavy atoms, respectively, which are comparable to the corresponding values for the previous structure. The peptide structures are also well converged: the RMSD values for the structured region of the peptide (the residues from pY to 2 positions) are 0.84(AE0.14) A Ê and 1.04(AE0.08) A Ê for the backbone and all heavy atoms, respectively, which are substantially improved from the corresponding values of 1.32(AE0.40) A Ê and 2.18(AE0.56) A Ê , respectively, in the previously published structures.
While Arg605, 617, and 620 were all arti®cially restrained to be in proximity to the phosphate moiety of the peptide in the previous structure, 6 only two of them, Arg605 and Arg620, show close contacts with the phosphate group in the re®ned struc- 
FHA2 Complex with pTXXL Peptide
ture without using arti®cial restraints: the average distances of 5.2(AE0.6) A Ê and 5.6(AE0.6) A Ê are observed between the P atom of pT peptide and the Arg605 and Arg620 C z atoms, whereas that of 9.2(AE0.9) A Ê is observed for Arg617. These results are similar to those for the FHA2-pT peptide complex. The similarity and difference between the two complexes are further elaborated in the following section.
Comparison between FHA2-pT peptide and FHA2-pY peptide interactions Figure 5 shows the ribbon diagrams of the structures of FHA2-pT peptide and FHA2-pY peptide complexes. In both structures, the peptides exist in an extended conformation, and recognize the same binding site on FHA2 by interacting mainly with the FHA2 loop residues located between b3/3 H , b3
H /4, b5/6, and b9/10. As discussed in our previous papers, 2, 6 it is noteworthy that the highly conserved residues (Gly604, Arg605, Ser619, His622, and Asn655 in FHA2) are found in the binding loops. These conserved residues are likely to be the common determinants for the phosphopeptide recognition, while other non-conserved or less conserved residues in the binding site could further ®ne-tune the ligand speci®city. It is interesting to observe that the leucine residue at the 3 position in the pT peptide and that at the 2 pos- ition in the pY peptide are located in a very similar place to interact with FHA2. This position change from 3 to 2 could be the consequence of the size difference between Thr and Tyr. This can explain why FHA2 is able to bind both pT and pY peptides.
Detailed interactions between FHA2 and the pT and pY peptides are shown in Figures 6 (stereo views) and 7 (diagrams). The FHA2-pT complex (Figures 6(a) and 7(a) ) shows that FHA2 interacts with the pT peptide via several H-bonds and hydrophobic contacts. The side-chains of Arg605, Ser619 and Arg620 could form H-bonds with the pT phosphate group. The side-chain of Asn655 forms H-bonds with the 1 (Gln) backbone carbonyl oxygen atom and the 3 (Leu) amide proton of the pT peptide. The Thr654 O g H forms an H-bond with the 2 (Glu) side-chain, and the backbone carbonyl oxygen atom of N616 forms one with the 1 (Gln) amide proton. The extensive hydrogenbonding network suggests that H-bonds play an important role in binding. It should be noted that, although the H-bonds are identi®ed using a rather loose cut-off criterion (distance between donor and acceptor heavy atoms less than 4.3 A Ê , regardless of the angle of approach), their existence is most likely real, considering the limitation of NMR techniques to detect the H-bonds involving amino acid side-chains.
For the FHA2-pT peptide complex (Figures 3  and 7(a) ), the most prominent NOEs come from the T654 methyl group with the pThr methyl and the Glu (at 2 position) alkyl groups, and from the I681 side-chain with the Leu (at position 3) methyl groups. These results indicate that the T654 and I681 residues of FHA2, and the pThr, Glu (at 2) and Leu (at 3) residues of the peptide, play most critical roles in the hydrophobic interactions in the complex.
The structure of the FHA2-pY peptide complex (Figures 6(b) and 7(b) ) shows interactions similar to those in the FHA2-pT peptide complex, except that some H-bonds and hydrophobic interactions are missing, which agrees with its weaker binding af®nity (K d $ 100 mM) compared to the pT peptide (K d $ 12.9 mM). It should be noted that tight-binding pY peptides were very insoluble and the pY peptide used for the complex structure (derived from Rad9) showed only modest af®nity to FHA2. 6 Like the FHA2-pT peptide complex, the pY phosphate group could interact with the side-chains of Arg605 and Arg620 via H-bonds. The hydrophobic interaction between pY and T654 seems to play an important role for binding. The Leu at position 2 of the pY peptide enhances the interaction by closely contacting with Ile681, similar to Leu at the 3 position of the pT peptide. hSAi are the ®nal 20 simulated annealing structures; SA is the mean structure obtained by averaging the coordinates of the individual SA structures best ®t to each other (excluding the¯exible N-terminal (573-574), loop (632-642 and 706-713) and C-terminal (730) residues, and the¯exible peptide (À4 to À1 and 4) residues); and (SA) r is the restrained minimized mean structure obtained by restrained minimization of the mean structure SA. The number of restraints is given in parentheses.
a None of the hSAi structures exhibited distance violations greater than 0.41 A Ê . b The torsion angle restaints were derived by using TALOS.
9 c E L-J is the Lennard-Jones van der Waals energy calculated with the X-PLOR PARMALLH6 protein parameters 16 and is not included in the target function for simulated annealing or restrained minimization.
d The¯exible loop (632-642 and 706-713) residues are excluded from the statistics. e The coordinate precision of hSAi is de®ned as the average atomic RMSD from the mean (SA) structure.
Comparison between FHA2-pT peptide and FHA1-pT peptide interactions
It is interesting that the Leu side-chains of both peptides (3 in pT and 2 in pY peptides, respectively) show strong NOEs with Ile681 in both FHA2 complexes, suggesting that this hydrophobic contact is a major determinant in the recognition of FHA2 with phosphopeptides. This interpretation is further supported by the observation that FHA1, which shows a strong preference for Asp at the 3 position, has glycine (Gly133) instead of Ile at the position corresponding to Ile681. The main determinant for FHA1 to recognize Asp at the 3 position appears to be the ionic interaction between the Arg83 and the Asp. 7, 8 The structure of the FHA2-pT peptide complex (Figures 6(a) and 7(a)) suggests that this conserved Arg residue (Arg617 in FHA2) likely forms a salt bridge with Asp683 (Figure 7(a) ), which is Gly (Gly135) in FHA1. Arg617 can also interact with Leu at the pT 3 position, but via hydrophobic contacts with its side-chain methylene groups rather than a saltbridge. These analyses provide detailed structural basis for the different ligand speci®city between FHA1 and FHA2, which can be further tested by site-speci®c mutagenesis.
Conclusion
The results presented here, along with the previous reports from our laboratory, 2, 6 have demonstrated that the FHA2 domain of Rad53 is able to bind both pY and pT peptides, with K d in the low micromolar range. Our results 5, 7 and others 8 also showed that the FHA1 domain from the same protein is highly speci®c to pT peptides. These results support our early hypothesis, that FHA domains could have dual speci®city, or different FHA domains could have different speci®city. Furthermore, comparison of the structures of various complexes has provided insight into the structural basis of the ligand speci®city of FHA1 and FHA2 domains.
However, it is important to note that the biological binding sites of both domains remain to be established. For the FHA1 domain, the binding results clearly suggest that Thr192 of Rad9 is most likely the phosphorylated residue recognized by FHA1, 5 but direct evidence is not available. For FHA2, both Thr603 and Tyr829 are possible candidates, but it could be neither, or both. Other approaches are needed to establish the biological binding sites of both domains, and to evaluate the biological relevance of the results obtained from combinatorial library analyses and binding analyses of short phosphopeptides. hSAi are the ®nal 22 simulated annealing structures; SA is the mean structure obtained by averaging the coordinates of the individual SA structures best ®t to each other (excluding the¯exible N-terminal (573-574), loop (632-642 and 706-713) and C-terminal (730) residues, and the¯exible peptide (À3 to À1 and 3) residues); and (SA) r is the restrained minimized mean structure obtained by restrained minimization of the mean structure SA. The number of restraints is given in parentheses.
a None of the hSAi structures exhibited distance violations greater than 0.34 A Ê . b The torsion angle restaints were derived by using TALOS.
Materials and Methods

Materials
The pT peptide library and pS peptide library used in this study were obtained as described. 5 The puri®ed Rad9-derived pT peptides used in this study were synthesized by Genemed Synthesis, Inc (S. San Francisco, CA). All other chemicals were obtained from Aldrich Chemical unless stated otherwise.
Protein expression and purification
The FHA2 domain (residues 573-730) of Rad53 containing GST at the N terminus was cloned into a pET29a() vector (Novagen) for the expression of GST fusion proteins (GST-FHA2) in Escherichai coli BL21 (DE3). The puri®cation of GST-FHA2 was performed using glutathione-agarose (Sigma) followed by removing the GST tag with thrombin (Sigma) digestion. The FHA2 proteins were ®nally puri®ed by gel-®ltration chromatography. The isotope-labeled proteins were expressed in M9 medium containing 15 NH 4 Cl and D-glucose-13 C 6 . The protein puri®cation was monitored throughout by SDS-PAGE analysis. Protein concentration was determined spectrophotometrically at 280 nm using an extinction coef®cient of 15,220 M À1 cm À1 .
Screening of pT peptide libraries
The pT peptide library (acetyl-AXXX(pT)XXXABBRMresin) used in this study was the same as that described. 5 The puri®ed FHA2 proteins were biotinylated with sulfo-NHS-biotin (in 1.2-fold excess), as described, The details of screening procedure were similar to the previous study. 5 Compared to a negative control in which the reaction was conducted without the biotinylated FHA2 yielding colorless beads, the positive blue beads were selected from the library and subjected to a ladder-generating Edman degradation. 5 The amino acid sequences of the selected peptides were identi®ed using a MALDI-TOF mass spectrometer (Re¯ex III, Bruker Daltonics).
NMR experiments and complex structure determinations
NMR experiments were performed on a Bruker DRX-800 or DMX-600 spectrometer at 20 C. The protein concentration was 0. A mixing time of 100 ms was used for all the NOESY data. The NOESY data were processed and analyzed using XWIN-NMR 2.6 (Bruker) or Felix 95.0 (Molecular Simulations Inc.). Structural calculations were conducted using a simulated annealing method 15 within X-PLOR, 16 using the distance restraints derived from the identi®ed NOEs and H-bonds as well as the backbone torsion angle restraints derived from the TALOS program. 9 The structures were analyzed by X-PLOR, 16 PROCHECK, 17 and MOLMOL. 18 The ®nal structures with lowest energy were selected from a total of 100 calculated ones. All structure Figures were generated with MOLMOL. 
Binding analysis by NMR
Peptide binding experiments were performed by recording a series of 2D 15 N-HSQC spectra 13 on uniformly 15 N-labeled FHA2 samples with different concentrations of peptides. The solution was maintained at pH 6.5 throughout the titration. The dissociation constants (K d ) are calculated by assuming single-site binding and fast exchange regime. 19 On this analysis, resonance shifts caused by peptide additions are described by normalized shifts Á p : (2) is used to obtain a preliminary estimate of its value, which, in turn, is fed into equation (3) and varied slightly until an optimal ®t is achieved as judged by the linear correlation coef®cient squared (r 2 ), keeping in mind its intercept should be equal to 1. The K d values obtained from the slope of equation (3) are listed in Table 1 .
Protein Data Bank accession numbers
Coordinates of the FHA2-pT peptide complex structure and the re®ned FHA2-pY peptide complex structure have been deposited in the RCSB PDB with accession numbers of 1K2N (the ensemble of 20 FHA2-pT structures), 1J4L (the minimized mean structure of FHA2-pT), 1k2m (the ensemble of 22 FHA2-pY structures) and 1J4K (the minimized mean structure of FHA2-pY), respectively. They will be released upon publication of this work. 
